New Medical Director Joins Dana-Farber Team in Londonderry

Nov 22, 2013 No Comments by

Jeanna Walsh, MD, has been named medical director of Dana-Farber/New Hampshire Oncology-Hematology (Dana-Farber/NHOH). Dr. Walsh has provided exceptional cancer care to patients in Londonderry since the facility opened in 2008. Her new appointment is effective November 15, 2013.

“I am honored and excited to take over the directorship of Dana-Farber’s Londonderry satellite,” said Walsh. “The clinic has developed into a key center of oncology care in southern New Hampshire. I hope to continue these traditions of high quality cancer care and work to enhance the excellent programs that support our patients, their families, and the broader community.”

Dr. Walsh will succeed Frederick M. Briccetti, MD, who has led Dana-Farber/NHOH since its opening five years ago. Dr. Briccetti will continue to see patients in Londonderry and will be actively involved in the clinical trial program.

“It has been my privilege to serve as medical director,” said Briccetti. “I am proud of how the collaboration between Dana-Farber and NHOH has enhanced the cancer care we are able to provide in southern New Hampshire.”

Dana-Farber/New Hampshire Oncology-Hematology has allowed patients access to the latest medical oncology treatment and an array of support services, including genetic screening and counseling, nutrition counseling, a resource area for patients and families, and pastoral care. Laboratory and diagnostic services are also conveniently located at the facility.

“Dr. Walsh is known for her commitment to quality patient care, operational excellence and forward-thinking stewardship,” said Andrew Norden, MD, MPH, medical director of Satellites and Network Affiliates at Dana-Farber. “She is an excellent choice to strengthen our clinical care and partnerships at our Londonderry center.”

Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center, designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women’s Hospital as Dana-Farber/Brigham and Women’s Cancer Center and it provides pediatric care with Boston Children’s Hospital as Dana-Farber/Children’s Hospital Cancer Center. Dana-Farber is the top ranked cancer center in New England and fifth nationally, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding.

Follow Dana-Farber on Twitter or Facebook.


About the author

Jacklynn has been a resident in Londonderry since the age of 5. She grew up in a quiet neighborhood and went through the great school system. She has fond memories of bike riding through town in the spring and summer, sledding in the winter, and apple and pumpkin picking in the fall. She now has children of her own and looks forward to raising them in the same town she enjoyed so much as a youth.
No Responses to “New Medical Director Joins Dana-Farber Team in Londonderry”

Leave a Reply